Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results

Formed Special Committee to oversee investment in PharmHouse Enhanced strategic exposure to cannabis 2.0 through investment in Dynaleo Achieved significant progress toward operating expense reduction targets Well-positioned for U.S. market development through key successes at TerrAscend – Canopy Rivers Inc. (the “Company” or “Canopy Rivers“) (TSX: RIV) (OTC: CNPOF) today released its unaudited condensed interim consolidated financialContinue reading “Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results”

Canopy Rivers Sets Filing Date for Q1 2021 Financial Results

– Canopy Rivers Inc. (“Canopy Rivers” or the “Company“) (TSX: RIV) (OTC: CNPOF) will report its first quarter fiscal year 2021 financial results before markets open on August 14, 2020. The Company’s unaudited condensed interim consolidated financial statements and management’s discussion and analysis of financial results for the three months ended June 30, 2020 will be available on the Company’sContinue reading “Canopy Rivers Sets Filing Date for Q1 2021 Financial Results”